Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123586633 | 12358663 | 3 | F | 201412 | 20160719 | 20160512 | 20160726 | EXP | GB-MHRA-ADR 23445432 | GB-ACCORD-040396 | ACCORD | 61.00 | YR | M | Y | 105.00000 | KG | 20160726 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123586633 | 12358663 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | STARTED IN EARLY 2015. | Y | 202553 | ||||||||||
| 123586633 | 12358663 | 2 | SS | INDAPAMIDE/INDAPAMIDE HEMIHYDRATE | INDAPAMIDE | 1 | Unknown | STRENGTH. 2.5 MG, QD | 80 | MG | Y | 0 | 2.5 | MG | QD | ||||
| 123586633 | 12358663 | 3 | SS | NATRILIX-SR | INDAPAMIDE | 1 | Unknown | STRENGTH 1.5 MG | 0 | 1.5 | MG | ||||||||
| 123586633 | 12358663 | 4 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Unknown | 0 | |||||||||||
| 123586633 | 12358663 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | DOSE INCREASED 20 MG IN MORNING, 40 MG IN EVENING FROM 15-FEB-2016, THEN REDUCED TO INITIAL DOSE. | 0 | 20 | MG | BID | |||||||
| 123586633 | 12358663 | 6 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | 0 | |||||||||||
| 123586633 | 12358663 | 7 | C | REGURIN | 2 | Unknown | 0 | ||||||||||||
| 123586633 | 12358663 | 8 | C | VALSARTAN. | VALSARTAN | 1 | Unknown | 80 MG, QD | 0 | 80 | MG | QD | |||||||
| 123586633 | 12358663 | 9 | C | BENDROFLUMETHIAZIDE | BENDROFLUMETHIAZIDE | 1 | U | 0 | 2.5 | MG | |||||||||
| 123586633 | 12358663 | 10 | C | CHLORTALIDONE | CHLORTHALIDONE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123586633 | 12358663 | 1 | Hypertension |
| 123586633 | 12358663 | 2 | Hypertension |
| 123586633 | 12358663 | 3 | Hypertension |
| 123586633 | 12358663 | 4 | Product used for unknown indication |
| 123586633 | 12358663 | 5 | Hypertension |
| 123586633 | 12358663 | 6 | Product used for unknown indication |
| 123586633 | 12358663 | 7 | Product used for unknown indication |
| 123586633 | 12358663 | 8 | Product used for unknown indication |
| 123586633 | 12358663 | 9 | Hypervolaemia |
| 123586633 | 12358663 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123586633 | 12358663 | OT |
| 123586633 | 12358663 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123586633 | 12358663 | Blood pressure increased | |
| 123586633 | 12358663 | Cerebrovascular accident | |
| 123586633 | 12358663 | Drug ineffective | |
| 123586633 | 12358663 | Glomerular filtration rate decreased | |
| 123586633 | 12358663 | Hypervolaemia | |
| 123586633 | 12358663 | Impaired quality of life | |
| 123586633 | 12358663 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123586633 | 12358663 | 1 | 2015 | 2015 | 0 | |
| 123586633 | 12358663 | 2 | 20141030 | 2015 | 0 | |
| 123586633 | 12358663 | 3 | 2015 | 0 | ||
| 123586633 | 12358663 | 9 | 20160210 | 20160220 | 0 |